chr13-20189407-C-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_004004.6(GJB2):c.175G>C(p.Gly59Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_004004.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Palmoplantar keratoderma-deafness syndrome Pathogenic:1
Variant summary: The GJB2 c.175G>C (p.Gly59Arg) variant involves the alteration of a conserved nucleotide and is located in N-terminal region of the protein (InterPro). 4/4 in silico tools predict a damaging outcome for this variant (PP3). This variant is absent in 121328 control chromosomes from ExAC (PM2). This variant has been reported in at least one patient with autosomal dominant palmoplanter keratoderma with deafness (Leonard_2005), and this variant as a confirmed de novo mutation with confirmed parentage (PS2). Other missense variants at this residue (namely p.Gly59Asp, p.Gly59Ala and p.Gly59Ser) have also been reported in association with autosomal dominant form of hearing loss with variable phenotypic expressivity (PM1, PM5). Multiple databases concluded its pathogenicity as pathogenic (PP5). Taken together, according to ACMG guideline, this variant is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at